{"patient_id": 57607, "patient_uid": "8489397-1", "PMID": 34631069, "file_path": "comm/PMC008xxxxxx/PMC8489397.xml", "title": "Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: A case report", "patient": "A 28-year-old man, with no systemic disease, presented with herpes-like skin lesions on his right upper eyelid. He received first dose AZD1222 vaccine on March 20, 2021, during the Iran national vaccination program. Besides the common post-vaccination signs and symptoms, 2 days later, burning sensation, and painful skin rashes, and blisters developed on his right upper eyelid (Figure ) followed by upper eyelid edema 3 days later (Figure ). Ocular examination was done by slit-lamp, which showed normal findings. Along with these findings, patient reported a history of a herpes simplex virus (HSV) infection following a trauma to the right eye with an object in his childhood. According to the patient, he has experienced periods of cold sore (herpes simplex labialis) ever since. Regarding clinical signs and symptoms and patient history, treatment was started based on the diagnosis of recurrent HSV lesion of the upper eyelid. Topical antibiotic therapy was administered for the patient including sulfacetamide 10% eye drop to treat probable bacterial superimposition and conjunctivitis and blepharitis because of severe periorbital edema and ketotifen eye drop, Vitamin A ointment to reduce itching and irritation. After 72 h, the patient reported blurred vision on the right eye. Ocular examinations were normal again. Seven days after the onset of the lesion, signs and symptoms disappeared, and treatments were discontinued.", "age": "[[28.0, 'year']]", "gender": "M", "relevant_articles": "{'18602338': 1, '18836475': 1, '32585280': 1, '33848321': 1, '28443092': 1, '32859241': 1, '33335323': 1, '33847085': 1, '33306989': 1, '31898531': 1, '19508374': 1, '10459967': 1, '34631069': 2}", "similar_patients": "{}"}